KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Enterprise Value (2016 - 2026)

Staar Surgical (STAA) has disclosed Enterprise Value for 17 consecutive years, with -$187.5 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Enterprise Value rose 18.64% year-over-year to -$187.5 million, compared with a TTM value of -$187.5 million through Jan 2026, up 18.64%, and an annual FY2026 reading of -$187.5 million, up 18.64% over the prior year.
  • Enterprise Value was -$187.5 million for Q1 2026 at Staar Surgical, up from -$192.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$187.5 million in Q1 2026 and bottomed at -$245.1 million in Q1 2024.
  • Average Enterprise Value over 5 years is -$210.2 million, with a median of -$207.6 million recorded in 2022.
  • The sharpest move saw Enterprise Value fell 25.43% in 2024, then rose 19.27% in 2025.
  • Year by year, Enterprise Value stood at -$211.6 million in 2022, then decreased by 4.29% to -$220.7 million in 2023, then decreased by 4.43% to -$230.5 million in 2024, then grew by 16.41% to -$192.7 million in 2025, then increased by 2.66% to -$187.5 million in 2026.
  • Business Quant data shows Enterprise Value for STAA at -$187.5 million in Q1 2026, -$192.7 million in Q3 2025, and -$189.9 million in Q2 2025.